BioCryst Pharmaceuticals
BCRX
BCRX
103 hedge funds and large institutions have $677M invested in BioCryst Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 38 increasing their positions, 15 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
47% more capital invested
Capital invested by funds: $461M → $677M (+$216M)
17% more funds holding
Funds holding: 88 → 103 (+15)
Holders
103
Holding in Top 10
3
Calls
$11.8M
Puts
$4.71M
Top Buyers
| 1 | +$64.1M | |
| 2 | +$22.2M | |
| 3 | +$21.2M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$17M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$11M |
Top Sellers
| 1 | -$16.7M | |
| 2 | -$14.6M | |
| 3 | -$12.3M | |
| 4 |
DM
Deerfield Management
New York
|
-$9.61M |
| 5 |
Millennium Management
New York
|
-$5.63M |